145 related articles for article (PubMed ID: 12646022)
1. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Descamps-François C; Yous S; Chavatte P; Audinot V; Bonnaud A; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
J Med Chem; 2003 Mar; 46(7):1127-9. PubMed ID: 12646022
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Wallez V; Durieux-Poissonnier S; Chavatte P; Boutin JA; Audinot V; Nicolas JP; Bennejean C; Delagrange P; Renard P; Lesieur D
J Med Chem; 2002 Jun; 45(13):2788-800. PubMed ID: 12061881
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
Mésangeau C; Pérès B; Descamps-François C; Chavatte P; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Bennejean C; Renard P; Caignard DH; Berthelot P; Yous S
Bioorg Med Chem; 2010 May; 18(10):3426-36. PubMed ID: 20444610
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
Ettaoussi M; Sabaouni A; Rami M; Boutin JA; Delagrange P; Renard P; Spedding M; Caignard DH; Berthelot P; Yous S
Eur J Med Chem; 2012 Mar; 49():310-23. PubMed ID: 22301214
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
Yous S; Durieux-Poissonnier S; Lipka-Belloli E; Guelzim H; Bochu C; Audinot V; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
Bioorg Med Chem; 2003 Mar; 11(5):753-9. PubMed ID: 12538005
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
[TBL] [Abstract][Full Text] [Related]
9. Design of subtype selective melatonin receptor agonists and antagonists.
Sugden D; Yeh LK; Teh MT
Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
[TBL] [Abstract][Full Text] [Related]
10. [Melatonin, a pertinent prototype for therapeutic innovation].
Lesieur D; Leclerc V; Chavatte P; Marot C; Renard P; Guardiola-Lemaitre B
Therapie; 1998; 53(5):429-37. PubMed ID: 9921034
[TBL] [Abstract][Full Text] [Related]
11. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
Leclerc V; Yous S; Delagrange P; Boutin JA; Renard P; Lesieur D
J Med Chem; 2002 Apr; 45(9):1853-9. PubMed ID: 11960497
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
Bioorg Med Chem; 1998 Oct; 6(10):1875-87. PubMed ID: 9839017
[TBL] [Abstract][Full Text] [Related]
14. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of melatonin receptors agonists and antagonists.
Tarzia G; Diamantini G; Mor M; Spadoni G
Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist.
Ettaoussi M; Sabaouni A; Pérès B; Landagaray E; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
ChemMedChem; 2013 Nov; 8(11):1830-45. PubMed ID: 24031039
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydronaphthalenic derivatives as new agonist and antagonist ligands for melatonin receptors.
Fourmaintraux E; Depreux P; Lesieur D; Guardiola-Lemaître B; Bennejean C; Delagrange P; Howell HE
Bioorg Med Chem; 1998 Jan; 6(1):9-13. PubMed ID: 9502101
[TBL] [Abstract][Full Text] [Related]
18. Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.
Rami M; Landagaray E; Ettaoussi M; Boukhalfa K; Caignard DH; Delagrange P; Berthelot P; Yous S
Molecules; 2012 Dec; 18(1):154-66. PubMed ID: 23262445
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay.
Conway S; Canning SJ; Howell HE; Mowat ES; Barrett P; Drew JE; Delagrange P; Lesieur D; Morgan PJ
Eur J Pharmacol; 2000 Feb; 390(1-2):15-24. PubMed ID: 10708702
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.
Tsotinis A; Vlachou M; Eleutheriades A; Prinea E; Ebreo D; The MT; Sugden D
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):31-9. PubMed ID: 11824582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
